These findings were confirmed by Toi et al., who showed that pre-existing positivity for commonly studied autoantibodies (ANA, RF and ATA) was associated with irAEs in a cohort of 137 patients with non-small cell lung cancer treated with nivolumab [28]. Here, ATM is linked to non-small cell lung carcinoma.